Abbott Laboratories (ABT) announced that the Food and Drug Administration has issued an "Emergency Use Authorization" for its molecular test that can detect a positive coronavirus diagnosis in as little as five minutes and a negative result in 13 minutes. The test runs on Abbott's point-of-care "ID Now" platform, a portable instrument that can be used in almost any health care setting. Traders have pushed up ABT this morning, so let's check out the charts and indicators for a longer time line than their test results.
More from Investing
These five key things will help make you successful at trading.
It can safely be said that no one saw this course of events coming.
While still reporting healthy revenue and billings growth, Slack and some other software high-flyers are also seeing some demand headwinds.
Other than taking profits, I'm not interested in putting on new trades.